Femasys
FEMY | NASDAQ
$1.28
-$0.14 (-9.86%)
At close: Nov 16, 2026, 4:00 PM ET
$1.30
+$0.02 (+1.56%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-9.86%
(1D)No price chart data available for 1D timeframe.
Rating
49.8
-5.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #290/1021 (Top 28%)
Key Statistics
Market Data
Market Cap $10.72M
1D Range
1.28 1.43
52W Range
1.28 20.20
Valuation (TTM)
PE -0.41
PB 0.40
EV/EBITDA 0.80
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $10.00
Cash Flow
FCF Yield -161.6%
SBC Adj. FCF Yield -166.8%
SBC Impact -3.2%
Margins
Gross Margin 50.8%
Operating Margin -929.9%
FCF Margin -877.5%
Growth (CAGR)
Revenue 3Y | 5Y 21.8% |
10.4%
Dil EPS 3Y | 5Y 59.2% |
24.8%
FCF 3Y | 5Y 2.3% |
-14.4%
Returns
ROA -36.1%
ROE -114.5%
ROIC -61.1%
Financial Health
Net Cash
$19.73M
Current Ratio 8.67
Interest Coverage -18.91
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line inclu...
Sector Healthcare
Industry Medical - Instruments & Supplies
Employees 53
IPO Date Jun 18, 2021
Website www.femasys.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 13, 2026
EPS
-$0.53
Beat +12.40%
YoY:
+73.50% REV
$404.6K
Miss -34.69%
YoY:
-44.53%Next Earnings
Apr 1, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$10.00
Upside
+681.25%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove FEMY